ADMAHealthcare · Biotechnology
ADMA Biologics Inc
DeepValues Research covers ADMA Biologics (ADMA) with 1 research report since Mar 25, 2026. The latest Deep Value Intelligence report (Mar 25, 2026) ends with a Neutral stance (3.37/5). Sector: Healthcare · Biotechnology.
Research timeline
-
Deep Value Intelligence
ADMA Biologics Inc (ADMA) Deep Value Intelligence ReportNeutral (3.37/5) on ADMA Biologics (ADMA), Mar 25, 2026. Price $10. WATCH (with room for a small "tracking" position). The "Why": ADMA Biologics is…
Compare with other Healthcare companies
All Healthcare stocks| Company | Latest stance | Reports |
|---|---|---|
| ADMAADMA Biologics | Neutral3.37 | 1 |
| ALLOAllogene Therapeutics | Bearish3.10 | 1 |
| MRNA | Neutral3.01 | 1 |
| CRSPCRISPR Therapeutics | Neutral2.30 | 1 |
| INSMInsmed | Bearish2.52 | 1 |
| GMABGenmab A/S | Bearish4.01 | 1 |
| MNKDMannKind | Neutral2.63 | 1 |
| TPSTTempest Therapeutics | Bearish2.65 | 1 |
| LENZLENZ Therapeutics | Bearish3.12 | 1 |
Charts from the latest report
Open report
